Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for...

  • Main
  • 2019 / 03
  • Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for...

Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study

Van Cutsem, Eric, Huijberts, Sanne, Grothey, Axel, Yaeger, Rona, Cuyle, Pieter-Jan, Elez, Elena, Fakih, Marwan, Montagut, Clara, Peeters, Marc, Yoshino, Takayuki, Wasan, Harpreet, Desai, Jayesh, Ciard
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.18.02459
Date:
March, 2019
File:
PDF, 749 KB
english, 2019
Conversion to is in progress
Conversion to is failed